Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03275597
Title Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition
Recruitment Active, not recruiting
Gender
Phase Phase I
Variant Requirements Yes
Sponsors University of Wisconsin, Madison
Indications

lung non-small cell carcinoma

Therapies

Durvalumab + Tremelimumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST